BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19913860)

  • 1. Blood-brain interfaces and cerebral drug bioavailability.
    Ghersi-Egea JF; Mönkkönen KS; Schmitt C; Honnorat J; Fèvre-Montange M; Strazielle N
    Rev Neurol (Paris); 2009 Dec; 165(12):1029-38. PubMed ID: 19913860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiology of blood-brain interfaces in relation to brain disposition of small compounds and macromolecules.
    Strazielle N; Ghersi-Egea JF
    Mol Pharm; 2013 May; 10(5):1473-91. PubMed ID: 23298398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detoxification systems, passive and specific transport for drugs at the blood-CSF barrier in normal and pathological situations.
    Strazielle N; Khuth ST; Ghersi-Egea JF
    Adv Drug Deliv Rev; 2004 Oct; 56(12):1717-40. PubMed ID: 15381331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases.
    Löscher W; Potschka H
    Prog Neurobiol; 2005 May; 76(1):22-76. PubMed ID: 16011870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane transporter proteins: a challenge for CNS drug development.
    Girardin F
    Dialogues Clin Neurosci; 2006; 8(3):311-21. PubMed ID: 17117613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers in the immature brain.
    Saunders NR; Knott GW; Dziegielewska KM
    Cell Mol Neurobiol; 2000 Feb; 20(1):29-40. PubMed ID: 10690500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain drug delivery, drug metabolism, and multidrug resistance at the choroid plexus.
    Ghersi-Egea JF; Strazielle N
    Microsc Res Tech; 2001 Jan; 52(1):83-8. PubMed ID: 11135451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The blood-brain barrier. II. Physiological data].
    Lefauconnier JM; Hauw JJ
    Rev Neurol (Paris); 1984; 140(1):3-13. PubMed ID: 6364292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain protection at the blood-cerebrospinal fluid interface involves a glutathione-dependent metabolic barrier mechanism.
    Ghersi-Egea JF; Strazielle N; Murat A; Jouvet A; Buénerd A; Belin MF
    J Cereb Blood Flow Metab; 2006 Sep; 26(9):1165-75. PubMed ID: 16395287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transporters of the blood-brain and blood-CSF interfaces in development and in the adult.
    Saunders NR; Daneman R; Dziegielewska KM; Liddelow SA
    Mol Aspects Med; 2013; 34(2-3):742-52. PubMed ID: 23506907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role of ABC transporters as a detoxification system at the blood-CSF barrier.
    de Lange EC
    Adv Drug Deliv Rev; 2004 Oct; 56(12):1793-809. PubMed ID: 15381334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barrier mechanisms in the brain, I. Adult brain.
    Saunders NR; Habgood MD; Dziegielewska KM
    Clin Exp Pharmacol Physiol; 1999 Jan; 26(1):11-9. PubMed ID: 10027064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and function of the blood-brain barrier.
    Abbott NJ; Patabendige AA; Dolman DE; Yusof SR; Begley DJ
    Neurobiol Dis; 2010 Jan; 37(1):13-25. PubMed ID: 19664713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug resistance in epilepsy: the role of the blood-brain barrier.
    Abbott NJ; Khan EU; Rollinson CM; Reichel A; Janigro D; Dombrowski SM; Dobbie MS; Begley DJ
    Novartis Found Symp; 2002; 243():38-47; discussion 47-53, 180-5. PubMed ID: 11990780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barrier mechanisms in the brain, II. Immature brain.
    Saunders NR; Habgood MD; Dziegielewska KM
    Clin Exp Pharmacol Physiol; 1999 Feb; 26(2):85-91. PubMed ID: 10065326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The blood-brain barrier in brain homeostasis and neurological diseases.
    Weiss N; Miller F; Cazaubon S; Couraud PO
    Biochim Biophys Acta; 2009 Apr; 1788(4):842-57. PubMed ID: 19061857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional effectiveness of the blood-brain barrier to small water-soluble molecules in developing and adult opossum (Monodelphis domestica).
    Ek CJ; Dziegielewska KM; Stolp H; Saunders NR
    J Comp Neurol; 2006 May; 496(1):13-26. PubMed ID: 16528724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential, strain-specific cellular and subcellular distribution of multidrug transporters in murine choroid plexus and blood-brain barrier.
    Soontornmalai A; Vlaming ML; Fritschy JM
    Neuroscience; 2006; 138(1):159-69. PubMed ID: 16361063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The blood-cerebrospinal fluid barrier: structure and functional significance.
    Johanson CE; Stopa EG; McMillan PN
    Methods Mol Biol; 2011; 686():101-31. PubMed ID: 21082368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood-brain interfaces and bilirubin-induced neurological diseases.
    Ghersi-Egea JF; Gazzin S; Strazielle N
    Curr Pharm Des; 2009; 15(25):2893-907. PubMed ID: 19754366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.